Key facts
- This page summarizes Herbert Virgin's Form 4 filing for Vir Biotechnology, Inc. (VIR).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 13 Jan 2022, 15:09.
Herbert Virgin - 11 Jan 2022 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)
- Reporting relationship
- EVP, Research & CSO
- Issuer ticker
- VIR
- Reported as of
- 11 Jan 2022
- Net transaction value
- -$46,159
- SEC form
- 4
- Accepted by SEC
- 13 Jan 2022, 15:09:41 UTC
- Prior SEC filing
- 30 Dec 2021
- Next SEC filing
- 26 Jan 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Howard Horn, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Herbert Virgin filed Form 4 for Vir Biotechnology, Inc. (VIR) on 13 Jan 2022.
Change
- Previous filing in this sequence was filed on 30 Dec 2021.
- Current net transaction value: -$46,159.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VIR
transaction
Common Stock
Options Exercise
- Transaction value
- $2,104
- Shares
- +1,375
- Change %
- +1.3%
- Price
- $1.53*
- Shares after
- 109,075
- Date
- 11 Jan 2022
- Ownership
- Direct
VIR
transaction
Common Stock
Sale
- Transaction value
- $48,262
- Shares
- -1,375
- Change %
- -1.3%
- Price
- $35.10
- Shares after
- 107,700
- Date
- 11 Jan 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VIR
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -1,375
- Change %
- -0.61%
- Price
- $0.000000
- Shares after
- 223,630
- Date
- 11 Jan 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,375
- Exercise price
- $1.53
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021.
Footnote F2
The option is fully vested and exercisable.